tempus – Lab DB

Pharmaceutical R&D

Daiichi Sankyo and Tempus AI collaborate on ADC clinical development

Teuku Ryan Mar 27, 2026 0

In a significant move poised to accelerate the innovation pipeline for antibody-drug conjugate (ADC) therapies, Japanese pharmaceutical giant Daiichi Sankyo…

Daiichi Sankyo and Tempus AI collaborate on ADC clinical development

YOU MAY HAVE MISSED

Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption

The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development

Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput

Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study